- In November 2022, Bio INX introduced Hydrobio INX 400, a ground-breaking material that enables live cell encapsulation in 3D printing using Nanoscribe's two-photon polymerization technology. This material is designed for cell encapsulation combined with cell seeding to create complex biomimetic tissues
- In March 2022, PharmaCyte Biotech, Inc. successfully completed a 24-month product stability study for its clinical trial product candidate, CypCaps, as required by the U.S. Food and Drug Administration (FDA). This milestone demonstrates that CypCaps can maintain a shelf life of at least 24 months when stored at -80°C
Frequently Asked Questions
The market is segmented based on Segmentation, By Manufacturing Techniques (Simple Dripping, Electrostatic Dripping, Coaxial Airflow, Liquid-Jet Break-Up, Vibrating-Jet Technique, Jet Cutting, and Rotating Disk Atomization), Polymer Type (Alginate, HEMA-MMA, Chitosan, Siliceous Encapsulates, Cellulose Sulphate, PAN-PVC, and Others), Application (Drug Delivery, Regenerative Medicine, Cell Transplantation, Probiotics, and Research) – Industry Trends and Forecast to 2032
.
The Global Live Cell Encapsulation Market size was valued at USD 222.18 USD Million in 2024.
The Global Live Cell Encapsulation Market is projected to grow at a CAGR of 2.69% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
